Stocksigma LogoStocksigma Logo

Akums Drugs Board to Consider Q2 Results on 2nd Nov'26

Akums Drugs and Pharmaceuticals Ltd has scheduled a Board of Directors meeting on 2nd Nov'26 to consider and approve the standalone and consolidated

Akums Drugs Board to Consider Q2 Results on 2nd Nov'26

Akums Drugs and Pharmaceuticals Ltd 路 Intimation 路 02 Nov 2026, 5:30 am

Akums Drugs Board to Consider Q2 Results on 2nd Nov'26 Akums Drugs and Pharmaceuticals Ltd has scheduled a Board of Directors meeting on 2nd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for company securities remains closed and will reopen 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Akums Drugs and Pharmaceuticals Ltd

All Akums Drugs and Pharmaceuticals Ltd announcements